ProKidney Corp. Enters Material Definitive Agreement
Ticker: PROK · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1850270
| Field | Detail |
|---|---|
| Company | Prokidney Corp. (PROK) |
| Form Type | 8-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $20.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
Related Tickers: PROK
TL;DR
PROK just signed a big deal, details to come.
AI Summary
On January 17, 2025, ProKidney Corp. entered into a material definitive agreement. The company, formerly known as Social Capital Suvretta Holdings Corp. III, is incorporated in the Cayman Islands and has its principal executive offices in Winston-Salem, North Carolina.
Why It Matters
This filing indicates a significant contractual development for ProKidney Corp., which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement is a significant event that could carry substantial implications for the company's future, warranting a medium risk assessment.
Key Numbers
- 001-40560 — SEC File Number (Identifies the company's filing with the SEC.)
- 98-1586514 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PROKIDNEY CORP. (company) — Registrant
- Social Capital Suvretta Holdings Corp. III (company) — Former Company Name
- January 17, 2025 (date) — Date of earliest event reported
- 2000 Frontis Plaza Blvd. Suite 250 (address) — Principal Executive Offices
- Winston-Salem, North Carolina (location) — Principal Executive Offices Location
FAQ
What is the nature of the material definitive agreement entered into by ProKidney Corp. on January 17, 2025?
The filing states that ProKidney Corp. entered into a 'Material Definitive Agreement' on January 17, 2025, but the specific details of this agreement are not provided in the excerpt.
When did ProKidney Corp. change its name from Social Capital Suvretta Holdings Corp. III?
The filing indicates that the date of the name change from Social Capital Suvretta Holdings Corp. III to ProKidney Corp. was March 10, 2021.
Where are ProKidney Corp.'s principal executive offices located?
ProKidney Corp.'s principal executive offices are located at 2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, North Carolina, 27103.
What is ProKidney Corp.'s SEC file number?
ProKidney Corp.'s SEC file number is 001-40560.
What is the SIC code for ProKidney Corp. and what does it represent?
The Standard Industrial Classification (SIC) code for ProKidney Corp. is 2836, which represents 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Filing Stats: 473 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-01-21 16:05:09
Key Financial Figures
- $0.0001 — h registered Class A ordinary shares, $0.0001 par value per share PROK The Nasdaq
- $20.5 million — sboro, North Carolina for approximately $20.5 million in cash. The Agreement contains customa
Filing Documents
- prok-20250117.htm (8-K) — 38KB
- 0000950170-25-007217.txt ( ) — 152KB
- prok-20250117.xsd (EX-101.SCH) — 25KB
- prok-20250117_htm.xml (XML) — 5KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On January 17, 2025, ProKidney Corp. (the "Company"), through its wholly owned subsidiary, ProKidney Acquisition Company, LLC, entered into a purchase and sales agreement with Stream Realty Acquisition, L.L.C. (the "Agreement") to sell the Company's real property located in Greensboro, North Carolina for approximately $20.5 million in cash. The Agreement contains customary representations for a transaction of this type. The transaction is expected to close in March 2025, subject to customary closing conditions. The foregoing description of the Agreement is qualified in its entirety by reference to the full text of such agreement, which the Company intends to file as an exhibit to its Annual Report on Form 10-K for the year ended December 31, 2024.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROKIDNEY CORP. Date: January 21, 2025 By: /s/ Todd Girolamo Name: Todd Girolamo Title: Chief Legal Officer